期刊文献+

实时荧光定量PCR法检测人粪便中艰难梭状芽孢杆菌 被引量:3

Real-time PCR method for detecting Clostridium difficile in human fecal tissue
原文传递
导出
摘要 目的摸索并明确实时荧光定量PCR技术检测人体肠道粪便中艰难梭状芽孢杆菌的方法。方法用16S rRNA real-time PCR方法检测喘息患儿与正常儿童肠道内梭状芽孢杆菌的数量。结果常规PCR扩增出艰难梭状芽孢杆菌16S rRNA部分基因片段长度为500 bp^750 bp,测序结果正确,符合预期,成功构建了艰难梭状芽孢杆菌实时荧光定量PCR中的标准品,生成的标准曲线r2>0.995;实时荧光定量PCR产物的溶解曲线为单峰,表明实时荧光定量PCR的特异性强。对待测80份样本分批进行荧光定量PCR检测,各组间标准品Ct值的变异系数(CV)为4.96%、3.45%、2.46%、2.43%和2.75%。80份儿童粪便样本中艰难梭状芽孢杆菌含量的对数值为3.70±2.71(copy/g湿便)。结论本研究表明,实时荧光定量PCR方法操作简便、灵敏度高、特异性强、自动化程度高,适用于人体粪便中艰难梭状芽孢杆菌含量的检测。 Objective To explore and identify the method of applying real- time fluorescence quantitative PCR technology for detecting Clostridium difficile in human intestinal tract fecal samples. Methods Evaluate the amount of Clostridium difficile between wheezy children and control group by 16 S rRNA real- time PCR method. Results The length of PCR product fragment which was used to build the standard curve was about 500 bp- 750 bp. The sequencing result was consist with the goals,and the standard sample of Clostridium difficile was successfully established in real- time fluorescence quantitative PCR. The standard curve showed a good linear relationship with r^2 〉0. 995. The primers were specific and the dissolve curve showed single peak. The CV of standards' Ct values which calculated from standard were 4. 96%,3. 45%,2. 46%,2. 43% and 2. 75%.The contents of Clostridium difficile in fecal from 80 children was 3. 70 ± 2. 71( copy / g wet fecal) transformed by logarithmic.Conclusion This study showed that real- time PCR was not only simple,easy operating,but also high specificity,sensitivity and automated. It is suitable for detecting Clostridium difficile in human intestinal tract fecal samples content.
出处 《中国卫生检验杂志》 CAS 2015年第3期305-307,共3页 Chinese Journal of Health Laboratory Technology
基金 国家自然科学基金青年科学基金项目(8130000210-06165)
关键词 实时荧光定量聚合酶链式反应 引物 标准曲线 艰难梭状芽孢杆菌 Real-time fluorescence quantitative polymerase chain reaction Primer Standard curve Clostridium difficile
  • 相关文献

参考文献4

二级参考文献35

  • 1沈秋生.难辨梭状芽孢杆菌致伪膜性肠炎的诊治现状[J].抗感染药学,2004,1(3):101-102. 被引量:8
  • 2Udayakumar Navaneethan,Preethi GK Venkatesh,Bo Shen.Clostridium difficile infection and inflammatory bowel disease:Understanding the evolving relationship[J].World Journal of Gastroenterology,2010,16(39):4892-4904. 被引量:12
  • 3Hall IC, O'Toole E. Intestinal flora in new-born infants with description of a new pathogenic anaerobe: Bacillus difficilis. Am J Dis Child, 1935, 48: 390-402.
  • 4Barbut F, Decre D, Lalande V, et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-speeific ADP-ribosyltransferase)-producing strains. J Med Microbial, 2005, 54:181-185.
  • 5Loo VG, Porrier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med, 2005, 353 : 2442-2449.
  • 6Ricciardi R, Rothenberger DA, Madoff RD, et al. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg, 2007,142: 624-631.
  • 7Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium diffieile-related mortality rates, United States, 1999-2004. Emerg Infect Dis ,2007,13 : 1417-1419.
  • 8Miller MA, Hyland M, Ofner-Agostini M, et al. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Contr Hosp Epidemiol, 2002, 23 : 137-140.
  • 9Hubert B, Loo VG, Bourgault AM, et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C difficile-associated disease in Quebec. Clin Infect Dis, 2007,44: 238-244.
  • 10United Kingdom national statistics. Newport, United Kingdom: Office for National Statistics, UK Statistics Authority. (Accessed October 6, 2008, at http://www, statistics, gov. uk. ).

共引文献17

同被引文献37

  • 1Miguel Gueimonde,Arthur Ouwehand,Heikki Huhtinen,Eeva Salminen,Seppo Salminen.Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease[J].World Journal of Gastroenterology,2007,13(29):3985-3989. 被引量:25
  • 2陈津津,蔡威.应用real-time PCR测定幼兔肠道内双歧杆菌和乳杆菌的变化[J].世界华人消化杂志,2007,15(31):3278-3283. 被引量:5
  • 3WAUGH D F, von HIPPEL P H. κ-Casein and the stabilization of casein micelles[J]. Joumal of the American Chemical Society, 1956, 78(18): 4576-4582.
  • 4DELFOUR A, JOLLES J, ALAIS C, et al. Caseino-glycopeptides: characterization of a methionine residue and of the N-terminal sequence[J]. Biochemical and Biophysical Research Communications, 1965, 19(4): 452-455.
  • 5GYORGY P, JEANLOZ R W, NICOLAI H, et al. Undialyzable growth factors for Lactobacillus bifidus var. pennsylvanicus[J]. European Journal of Biochemistry, 1974, 43(1): 29-33.
  • 6SCHELL M A, KARMIRANTZOU M, SNEL B, et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract[J]. Proceedings of the National Academy of Sciences, 2002, 99(22): 14422-14427.
  • 7DONG Ping, YANG Yi, WANG Weiping. The role of intestinal bifidobacteria on immune system development in young rats[J]. Early Human Development, 2010, 86(1): 51-58.
  • 8KOK R G, WAAL A D, SCHUT F, et al. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces[J]. Applied and Environmental Microbiology, 1996, 62(10): 3668-3672.
  • 9MATSUKI T, WATANABE K, FUJIMOTO J, et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces[J]. Applied and Environmental Microbiology, 2002, 68(11 ): 5445-5451.
  • 10MATSUKI T, WATANABE K, FUJIMOTO J, et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces[J]. Applied and Environmental Microbiology, 2004, 70(12): 7220-7228.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部